BOLT
Price
$6.24
Change
+$0.24 (+4.00%)
Updated
Oct 27, 04:59 PM (EDT)
Capitalization
11.52M
Intraday Buy/Sell Signals
XENE
Price
$41.80
Change
+$1.04 (+2.55%)
Updated
Oct 27, 02:52 PM (EDT)
Capitalization
3.14B
9 days until earnings call
Intraday Buy/Sell Signals
Interact to see
Advertisement

BOLT vs XENE

Header iconBOLT vs XENE Comparison
Open Charts BOLT vs XENEBanner chart's image
Bolt Biotherapeutics
Price$6.24
Change+$0.24 (+4.00%)
Volume$100
Capitalization11.52M
Xenon Pharmaceuticals
Price$41.80
Change+$1.04 (+2.55%)
Volume$200
Capitalization3.14B
BOLT vs XENE Comparison Chart in %
BOLT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XENE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BOLT vs. XENE commentary
Oct 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BOLT is a StrongBuy and XENE is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 27, 2025
Stock price -- (BOLT: $6.00 vs. XENE: $40.76)
Brand notoriety: BOLT and XENE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BOLT: 45% vs. XENE: 117%
Market capitalization -- BOLT: $11.52M vs. XENE: $3.14B
BOLT [@Biotechnology] is valued at $11.52M. XENE’s [@Biotechnology] market capitalization is $3.14B. The market cap for tickers in the [@Biotechnology] industry ranges from $108.04B to $0. The average market capitalization across the [@Biotechnology] industry is $2.04B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BOLT’s FA Score shows that 1 FA rating(s) are green whileXENE’s FA Score has 1 green FA rating(s).

  • BOLT’s FA Score: 1 green, 4 red.
  • XENE’s FA Score: 1 green, 4 red.
According to our system of comparison, XENE is a better buy in the long-term than BOLT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BOLT’s TA Score shows that 6 TA indicator(s) are bullish while XENE’s TA Score has 4 bullish TA indicator(s).

  • BOLT’s TA Score: 6 bullish, 3 bearish.
  • XENE’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, BOLT is a better buy in the short-term than XENE.

Price Growth

BOLT (@Biotechnology) experienced а +4.33% price change this week, while XENE (@Biotechnology) price change was -2.09% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.61%. For the same industry, the average monthly price growth was +11.19%, and the average quarterly price growth was +64.92%.

Reported Earning Dates

XENE is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (-0.61% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
XENE($3.14B) has a higher market cap than BOLT($11.5M). XENE YTD gains are higher at: 3.980 vs. BOLT (-43.936). BOLT has higher annual earnings (EBITDA): -51.83M vs. XENE (-315.5M). XENE has more cash in the bank: 488M vs. BOLT (34.8M). XENE has less debt than BOLT: XENE (8.72M) vs BOLT (24.2M). XENE has higher revenues than BOLT: XENE (7.5M) vs BOLT (4.17M).
BOLTXENEBOLT / XENE
Capitalization11.5M3.14B0%
EBITDA-51.83M-315.5M16%
Gain YTD-43.9363.980-1,104%
P/E RatioN/AN/A-
Revenue4.17M7.5M56%
Total Cash34.8M488M7%
Total Debt24.2M8.72M278%
FUNDAMENTALS RATINGS
XENE: Fundamental Ratings
XENE
OUTLOOK RATING
1..100
23
VALUATION
overvalued / fair valued / undervalued
1..100
73
Overvalued
PROFIT vs RISK RATING
1..100
35
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
44
P/E GROWTH RATING
1..100
6
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BOLTXENE
RSI
ODDS (%)
N/A
Bearish Trend 4 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
75%
Bearish Trend 4 days ago
73%
Momentum
ODDS (%)
Bullish Trend 4 days ago
71%
Bullish Trend 4 days ago
76%
MACD
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
78%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
76%
Bearish Trend 4 days ago
75%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
79%
Bullish Trend 4 days ago
75%
Advances
ODDS (%)
Bullish Trend 4 days ago
73%
Bullish Trend 13 days ago
72%
Declines
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 4 days ago
70%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
80%
Aroon
ODDS (%)
Bullish Trend 4 days ago
87%
Bullish Trend 4 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
BOLT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XENE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JSGIX32.250.33
+1.03%
JHancock U.S. Growth I
RRREX22.190.07
+0.32%
DWS RREEF Real Estate Securities S
TADGX86.180.20
+0.23%
T. Rowe Price Dividend Growth Advisor
LCFLX14.940.01
+0.07%
Lord Abbett Focused Large Cap Value C
ITFEX12.69N/A
N/A
Voya International High Div Low Vol S2

BOLT and

Correlation & Price change

A.I.dvisor tells us that BOLT and DYN have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BOLT and DYN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BOLT
1D Price
Change %
BOLT100%
+4.17%
DYN - BOLT
32%
Poorly correlated
+3.82%
ERAS - BOLT
32%
Poorly correlated
+7.69%
NRIX - BOLT
32%
Poorly correlated
+6.63%
XENE - BOLT
32%
Poorly correlated
-1.07%
BMRN - BOLT
32%
Poorly correlated
-0.13%
More